SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-16-000568
Filing Date
2016-05-16
Accepted
2016-05-16 17:04:42
Documents
5
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED MARCH 31, 2016 nymox6kq1fs.htm 6-K 5533
2 QUARTERLY REPORT FOR THE QUARTER ENDED MARCH 31, 2016 exhibit99-1.htm EX-99.1 242224
3 CEO CERTIFICATIONS exhibit99-2.htm EX-99.2 8860
4 CFO CERTIFICATIONS exhibit99-3.htm EX-99.3 8792
5 exhibit99-1x1x1.jpg GRAPHIC 10692
  Complete submission text file 0001176256-16-000568.txt   281310
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 161654943
SIC: 2835 In Vitro & In Vivo Diagnostic Substances